30 Years of Evidence
Join the experts’ corner
Featured Content
SBRT Focal Boost for Localised Prostate Cancer: Primary Outcomes of the SPARC Prospective Trial
Efficacy and Toxicity of Moderately Hypofractionated Radiotherapy via Helical TomoTherapy versus Conventional Radiotherapy Combined with Concurrent Chemotherapy for Patients with Unresectable
Stage III NSCLC
Feasibility of SBRT with CyberKnife in the Scenario of Lung Metastases Re-RT: Monoinstitutional Experience
SBRT Versus ENRT for Lymph-nodal Relapses in Gynaecological Cancers
Martina Midulla et al. | Abstract 2783 | ESTRO | 2024
Adaptive RT Concomitant to Oxaliplatin Based Chemotherapy as Preoperative Treatment for Rectal Cancer
Giorgio Purrello et al. | Abstract 2304 | ESTRO | 2024
Independent Validation of Real-time Prostate Localization for MLC Tracking in Phantoms and Patients
Klara Stefansson et al. | Abstract 757 | ESTRO | 2024
Dose Tracking in Head and Neck Cancer – Possible Benefits with Adaptive Radiotherapy
Hedda Enocson et al. | Abstract 1210 | ESTRO | 2024
Intensified Total Marrow Irradiation in High-risk HSCT Patients
Simonetta Saldi et al. | Abstract 3109 | ESTRO | 2024
Modern radiotherapy for extended cutaneous lesions from lymphomas: results from a multicenter study
Mario Levis et al. | Abstract 1270 | ESTRO | 2024
Efficacy and toxicity of moderately hypofractionated radiotherapy via helical TomoTherapy versus conventional radiotherapy combined with concurrent chemotherapy for patients with unresectable stage III non-small cell Lung Cancer: a multicenter, randomized phase III trial Chinese clinical trial registration: ChiCTR1800017367
Huang Wenhan et al. | Abstract 3407 | ESTRO | 2024
Automation of the Couch Sag Quality Control Test for Accuray Radixact
Guillermo Camacho et al. | Abstract 2309 | ESTRO | 2024
Automation of Dose Stability Test in Helical Irradiations on TomoTherapy Linear Accelerators
Rodrigo Astudillo Olalla, Fernando Gómez Enriquez, Marina Gutierrez Ruiz, Noelia Suárez Álvarez, Rosa Fabregat | Abstract 1998 | ESTRO | 2024
Intensity-modulated Radiotherapy and Cisplatin-based Chemotherapy for Anal Cancer: Long-term Outcomes at a Single Institution
Gerardi MA, Zerella MA, Bergamaschi L, Ferrari A, Arculeo S, Bagnardi V, Frassoni S, Petz W, Fodor C, Emiro F, Cattani F, Leonardi MC, Zampino
Performance Evaluation of Online Motion Synchronizing Systems for Patient-Specific Respiratory Movements with Helical TomoTherapy
Chan WKC, Fok TC, Chiu TL, Yu SK. | Biomed Phys Eng Express. | 2022
Total Skin Treatment with Helical Arc Radiotherapy
Nien HH, Hsieh CH, Shueng PW, Tien HJ | Int J Mol Sci | 2023
Clinical Study of Total Bone Marrow Combined with Total Lymphatic Irradiation Pretreatment Based on TomoTherapy in Hematopoietic Stem Cell Transplantation of Acute Leukemia
Kong F, Liu S, Liu L, Pi Y, Pei Y, Xu D, Jia F, Han B, Guo Y. | Front Oncol | 2023
Whole Body Irradiation with Intensity-Modulated Helical TomoTherapy Prior to Haematopoietic Stem Cell Transplantation: Analysis of Organs at Risk by Dose and its Effect on Blood Kinetics
Köksal M, Baumert J, Jazmati D, Schoroth F, Garbe S, Koch D, Scafa D, Sarria GR, Leitzen C, Massoth G, Delis A, Heine A, Holderried
Moderately Hypofractionated Helical TomoTherapy for Prostate Cancer: Ten-year Experience of a Mono-institutional Series of 415 Patients
Cozzi S, Ruggieri MP, Alì E, Ghersi SF, Vigo F, Augugliaro M, Giaccherini L, Iori F, Najafi M, Bardoscia L, Botti A, Trojani V, Ciammella
Quality of Life in Head and Neck Cancer Patients – A Prospective Longitudinal Study (FEMH 110183-E)
Yu-Hsuan Chuang et al. | Abstract 1499 | ESTRO | 2024
Initial Clinical and Dosimetric Outcomes with TBI Planned on Helical TomoTherapy
Varghese Antony et al. | Abstract 2797 | ESTRO | 2024
Clinical Outcome and Dosimetric Feasibility of Hippocampal Sparing Whole Brain Radiotherapy
Bhuvana J et al. | Abstract 1546 | ESTRO | 2024
Moderate Hypofractionation with Simultaneous Integrated Boost after Conservative Surgery for Breast Cancer
Roberta Tummineri et al. | Abstract 2485 | ESTRO | 2024
Left Breast Cancer Dosimetry with Accuray VOLO Ultra Optimizer: A Comparison with DIBH
Patrizia Urso et al. | Abstract 1363 | ESTRO | 2024
SABR for Liver De Novo, Repeat, and Induced Oligometastatic Disease
Miriam Torrisi et al. | Abstract 1735 | ESTRO | 2024
Reduction of Side Effects by Protecting the Tongue as Organ at Risk: A Planning/Feasibility Study
Andrea Renate Glasmacher et al. | Abstract 1810 | ESTRO | 2024
SBRT Versus ENRT for Lymph-nodal Relapses in Gynaecological Cancers
Martina Midulla et al. | Abstract 2783 | ESTRO | 2024
